Global Clinical Laboratory Services Market US$ 293 Million by 2023

The global clinical laboratory diagnostic services market to reach nearly US$ 293 Million by 2023, growing at a CAGR of 5.5% over the forecast period, due to its unique advantage such as early disease diagnosis and rising geriatric population worldwide.

Clinical Laboratory Diagnostic Services Market

The clinical laboratory has recently been defined as ‘the nerve center of diagnostic medicine’ because it provides essential information not only for diagnosis and monitoring, but also for screening, prevention, early diagnosis, tailored treatment and the more effective monitoring of human diseases. Clinical l

Advertisements

The global clinical laboratory diagnostic services market to reach nearly US$ 293 Million by 2023, growing at a CAGR of 5.5% over the forecast period, due to its unique advantage such as early disease diagnosis and rising geriatric population worldwide.

Clinical Laboratory Diagnostic Services Market

The clinical laboratory has recently been defined as ‘the nerve center of diagnostic medicine’ because it provides essential information not only for diagnosis and monitoring, but also for screening, prevention, early diagnosis, tailored treatment and the more effective monitoring of human diseases. Clinical laboratories provide testing primarily focused on medical care (e.g. emergency care, inpatients, and outpatient clinics).

The major changes experienced by laboratory medicine in the last few decades is the outcome of both technological and scientific progress. The shortened turnaround times to technological developments has made results available in real-time and dramatically improved the diagnosis and treatment of patients admitted to emergency departments and intensive care units. The availability of pivotal diagnostic information (e.g., blood-gas, electrolytes, disease biomarkers) at the point-of-care, and within a few minutes, allows clinicians to make evidence-based medical decisions and to immediately prioritize the treatment of patients. The extraordinary advancements in the molecular and biochemical bases of human diseases have paved the way for the introduction into the clinical practice of a new generation of laboratory tests for earlier and more accurate diagnoses, as well as for the identification of important risk factors.

The global clinical laboratory diagnostic services market report estimates the market size (US$ million 2015 to 2023) and segmented and forecast (CAGR% 2018 to 2023). It also analyses the major companies operating in the global market. The global clinical laboratory services market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

Major players operating in the global clinical laboratory services market and included in this report are Quest Diagnostics, Inc., Laboratory Corporation of America Holdings (LabCorp), Sonic Healthcare, Genoptix Medical Laboratory, Labco S.A., Healthscope Ltd., Bio-Reference Laboratories, and Bioscientia Healthcare.

The global clinical laboratory services market is segmented as:

  1. Clinical Diagnostics Test
    • Clinical Chemistry
    • Human & Tumor Genetics
    • Medical Microbiology & Cytology
    • Other Esoteric Tests
  1. Service Provider
    • Clinic-based
    • Hospital-based
    • Stand-alone
  1. Geography (Region, Country)
    • North America (U.S., Canada)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Rest of the World
  1. Company Profiles
    • Abbott Laboratories
    • ARUP Laboratories
    • Bio-Reference Laboratories
    • Bioscientia Healthcare
    • Charles River Laboratories
    • Genoptix Medical Laboratory
    • Healthscope Ltd.
    • Labco S.A.
    • Laboratory Corporation of America Holdings (Labcorp)
    • Quest Diagnostics, Inc.
    • Sonic Healthcare Limited
    • Spectra Laboratories

To request Table of Contents and Sample Pages of this report visit:
https://www.ihealthcareanalyst.com/report/clinical-laboratory-services-market/

Global Clinical Laboratory Services Market US$ 293 Million by 2023

Global Compression Therapy Devices Market US$ 3.7 Billion by 2023

The global compression therapy devices market is estimated to reach US$ 3.7 Billion by 2023, expanding at a CAGR of 4.8% over the forecast period, owing to sport injuries and boost in orthopedic surgeries worldwide.

Compression Therapy Devices Market

The compression therapy devices are used to treat phlebitis, thrombosis and aftercare following surgery, sclerotherapy and any other forms of varicose vein treatment, and also to relieve all conditions of chronic venous disease (heavy legs, varicose veins, oedemas, leg ulcers). It can also be prescribed to prevent venous issues during pregnancy and long distance travel. The global <a href="https://www.ihealthcareanalyst.com/report

The global compression therapy devices market is estimated to reach US$ 3.7 Billion by 2023, expanding at a CAGR of 4.8% over the forecast period, owing to sport injuries and boost in orthopedic surgeries worldwide.

Compression Therapy Devices Market

The compression therapy devices are used to treat phlebitis, thrombosis and aftercare following surgery, sclerotherapy and any other forms of varicose vein treatment, and also to relieve all conditions of chronic venous disease (heavy legs, varicose veins, oedemas, leg ulcers). It can also be prescribed to prevent venous issues during pregnancy and long distance travel. The global compression therapy devices market report provides market size estimates (US$ million 2015 to 2023) for key market segmented by the device type (elastic compression bandages, compression pumps, compression stockings, compression tapes, intermittent pneumatic compression, and sequential compression devices) and underlying static and dynamic technologies, and forecast (CAGR% 2018 to 2023). The global compression therapy devices market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

The report also provides the detailed market landscape and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and/or services offered, and recent trends in strategic management. Major players operating in the global compression therapy devices market and included in this report are 3M Health Care, ArjoHuntleigh, BSN medical, Getinge Group, Hartmann AG, Medtronic plc, Bio Compression Systems, Inc., medi GmbH & Co. KG, PAUL HARTMANN AG, and SIGVARIS MANAGEMENT AG.

The global compression therapy devices market is segmented as:

  1. Device Type
    • Elastic Compression Bandage
    • Compression Pump
    • Compression Stocking
    • Compression Tape
    • Intermittent Pneumatic Compression
    • Sequential Compression Devices (SCD)
  1. Technology
    • Dynamic
    • Static
  1. Geography (Region, Country)
    • North America (U.S., Canada)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Rest of the World
  1. Company Profiles
    • 3M Health Care
    • ArjoHuntleigh
    • Bio Compression Systems, Inc.
    • BSN medical
    • medi GmbH & Co KG
    • Medtronic plc (Covidien)
    • Paul Hartmann AG
    • Sigvaris Management AG
    • Smith & Nephew plc.

To request Table of Contents and Sample Pages of this report visit:
https://www.ihealthcareanalyst.com/report/compression-therapy-devices-market/

Global Compression Therapy Devices Market US$ 3.7 Billion by 2023

Global Cervical Cancer Diagnostics Market US$ 10 Billion by 2023

The global cervical cancer diagnostic testing market is estimated to reach US$ 10 Billion by 2023, expanding at a CAGR of 5.5% over the forecast period, due to higher incidence of HPV infections worldwide.

Cervical Cancer Diagnostics Market

Cervical cancer is caused due to human papillomavirus (HPV) infection and Worldwide, it is the fourth-most common cause of cancer and the fourth-most common cause of deaths from cancer in women.

<img class="aligncenter" title="Cervical-Cancer-Incidence" src="https://www.ihealthcareanalyst.com/wp-admin/admin-ajax.php?action=useyourdrive-embed-image&id=1hy8CZHjYbBGpol2ceA7hADK0iNyc4Utz&quot; alt="Cervical-Cancer-Incidence" width="912" h

The global cervical cancer diagnostic testing market is estimated to reach US$ 10 Billion by 2023, expanding at a CAGR of 5.5% over the forecast period, due to higher incidence of HPV infections worldwide.

Cervical Cancer Diagnostics Market

Cervical cancer is caused due to human papillomavirus (HPV) infection and Worldwide, it is the fourth-most common cause of cancer and the fourth-most common cause of deaths from cancer in women.

Cervical-Cancer-Incidence

The global cervical cancer diagnostics market report estimates the market size (US$ million 2015 to 2023) for market segmentation based on diagnostic test type (cervical biopsy, colposcopy, endocervical curettage, HPV typing, LEEP, pap smear testing, and imaging tests for stage detection such as CT or CAT, MRI, PET, chest X-ray, etc.), and forecast (CAGR% 2018 to 2023).

Cervical-Cancer-PrevalenceThe global cervical cancer diagnostic testing market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

The report also provides the detailed market landscape and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent acquisitions and alliances. Major players operating in the global cervical cancer diagnostic testing market and included in this report are Abbott Laboratories, Becton, Dickinson and Company, Hologic, Inc., F. Hoffmann-La Roche Ltd., Quest Diagnostics, Inc., QIAGEN N.V., Femasys, Inc., Zilico Ltd., Guided Therapeutics, Inc., OncoHealth Corp.

The global cervical cancer diagnostics market is segmented as:

  1. Diagnostic Test Type
    • Cervical Biopsy
    • Colposcopy
    • Endocervical Curettage (ECC)
    • Human Papilloma Virus (HPV) Typing
    • Loop Electrosurgical Excision Procedure (LEEP)
    • Pap Smear Testing
    • Others
  1. Imaging Tests for Stage Detection
    • CT or CAT (Computed Axial Tomography)
    • MRI (Magnetic Resonance Imaging)
    • PET (Positron Emission Tomography)
    • Chest X-ray
  1. Geography (Region, Country)
    • North America (U.S., Canada)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Rest of the World
  1. Company Profiles
    • Abbott Laboratories
    • Becton, Dickinson and Company
    • Hoffmann-La Roche Ltd.
    • Femasys, Inc.
    • Guided Therapeutics, Inc.
    • Hologic, Inc.
    • OncoHealth Corp.
    • Qiagen N.V.
    • Quest Diagnostics, Inc.
    • Zilico Ltd.

To request Table of Contents and Sample Pages of this report visit:
https://www.ihealthcareanalyst.com/report/cervical-cancer-diagnostic-testing-market/

Global Cervical Cancer Diagnostics Market US$ 10 Billion by 2023

Global Interventional Cardiology Devices Market US$ 10.5 Billion by 2023

The global interventional cardiology devices market is estimated to reach US$ 10.5 Billion by 2023, growing at a CAGR of 3% over the forecast period, owing to higher prevalence of coronary artery diseases.

Interventional Cardiology Devices Market

Interventional cardiology involves various non-surgical procedures for treating cardiovascular disease by using drug-eluting stents, bare-metal stents, percutaneous transluminal coronary angioplasty (PTCA) and cutting balloon catheters.

<img class="aligncenter" title="Cardiomyopathy-Myocarditis-Incidence" src="https://www.ihealthcareanalyst.com/wp-admin/admin-ajax.php?action=useyourdrive-embed

The global interventional cardiology devices market is estimated to reach US$ 10.5 Billion by 2023, growing at a CAGR of 3% over the forecast period, owing to higher prevalence of coronary artery diseases.

Interventional Cardiology Devices Market

Interventional cardiology involves various non-surgical procedures for treating cardiovascular disease by using drug-eluting stents, bare-metal stents, percutaneous transluminal coronary angioplasty (PTCA) and cutting balloon catheters.

Cardiomyopathy-Myocarditis-IncidenceThe global interventional cardiology devices market report provides market size estimates (US$ million 2015 to 2023) for key market segmented by the type of device used (stents – bare metal, bioabsorbable, drug eluting; catheters – angiography, guiding, IVUS, pulmonary arterial catheters; PTCA balloons – normal, drug eluting, cutting, scoring; imaging systems such as FFR, IVUS, OCT; PTCA guidewires, etc.), and forecast (CAGR% 2018 to 2023).

Cardiomyopathy-Myocarditis-PrevalenceThe global interventional cardiology devices market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

The report also provides the detailed market landscape and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and/or services offered, and recent trends in strategic management. Major players operating in the global interventional cardiology devices market and included in this report are Abbott Laboratories, Inc., B. Braun Melsungen AG, Boston Scientific Corporation, Cook Medical, Cordis Corporation, Medtronic, plc, St. Jude Medical, Inc., Smiths Medical, and Terumo Medical Corporation.

The global interventional cardiology devices market is segmented as:

  1. Device Type
    • Stents
      • Bare Metal Stents
      • Bio-absorbable Stents
      • Drug-Eluting Stents
    • Catheters
      • Angiography Catheters
      • Guiding Catheters
      • Intravascular ultrasound (IVUS) Catheters
      • Pulmonary Artery Catheters
    • Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons
      • Cutting Balloons
      • Drug-eluting Balloons
      • Normal Balloons
      • Scoring Balloons
    • Imaging Systems
      • Fractional Flow Reserve (FFR)
      • Intravascular Ultrasound (IVUS)
      • Optical Coherence Tomography (OCT)
    • PTCA Guidewires
    • Others
  1. Geography (Region, Country)
    • North America (U.S., Canada)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Rest of the World
  1. Company Profiles
    • Abbott Laboratories, Inc.
    • Braun Melsungen AG
    • Boston Scientific Corporation
    • Cook Medical, Inc.
    • Johnson & Johnson (Cordis Corporation)
    • Medtronic, Inc.
    • Smiths Medical
    • Jude Medical, Inc.
    • Terumo Corporation

To request Table of Contents and Sample Pages of this report visit:
https://www.ihealthcareanalyst.com/report/interventional-cardiology-devices-market/

Global Interventional Cardiology Devices Market US$ 10.5 Billion by 2023

Global Angioplasty Balloons Market US$ 2.5 Billion by 2023

The global angioplasty balloons market growing at the rate of 4.5% CAGR and estimated to reach US$ 2.5 Billion by 2023, due to high prevalence of coronary artery diseases and geriatric population.

Angioplasty Balloons Market

Angioplasty balloons widens the narrow or obstructed blood vessel using a balloon catheter to treat atherosclerosis (blood vessel obstructions).

Stroke-IncidenceThe global <a href="https://www.ihealthcareanaly

The global angioplasty balloons market growing at the rate of 4.5% CAGR and estimated to reach US$ 2.5 Billion by 2023, due to high prevalence of coronary artery diseases and geriatric population.

Angioplasty Balloons Market

Angioplasty balloons widens the narrow or obstructed blood vessel using a balloon catheter to treat atherosclerosis (blood vessel obstructions).

Stroke-IncidenceThe global angioplasty balloons market report estimates the market size (US$ million 2015 to 2023) for key market segmented by balloon type (normal, cutting, drug coated and scoring balloons), materials used (non-compliant and semi-compliant balloons), and forecast (CAGR% 2018 to 2023). The global angioplasty balloons market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

Stroke-PrevalenceThe report also provides the detailed market landscape and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. Major players profiled in this report include Abbott Laboratories, Inc., BIOTRONIK SE & CO. KG, Boston Scientific Corporation, Cook Medical, Cordis Corporation, C. R. Bard, Inc., ENDOCOR GmbH, Medtronic plc, Opto Circuits (India) Limited, NATEC Medical, and Spectranetics Corporation.

The global angioplasty balloons market is segmented as:

  1. Balloon Type
    • Cutting Balloon
    • Drug coated Balloon
    • Normal Balloon
    • Scoring Balloon
  1. Material Type
    • Non-compliant Balloon
    • Semi-compliant Balloon
  1. Geography (Region, Country)
    • North America (U.S., Canada)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Rest of the World 
  1. Company Profiles
    • Abbott Vascular
    • BIOTRONIK SE & Co.KG
    • Boston Scientific Corporation
    • R. Bard, Inc.
    • Cook Medical, Inc.
    • ENDOCOR GmbH
    • Johnson & Johnson (Cordis Corporation)
    • Medtronic, plc
    • NATEC Medical Limited
    • Spectranetics Corporation

To request Table of Contents and Sample Pages of this report visit:
https://www.ihealthcareanalyst.com/report/angioplasty-balloons-market/

Global Angioplasty Balloons Market US$ 2.5 Billion by 2023